Clinical Cancer Research Versailles No Abst Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urquidi, V.
Right arrow Articles by Goodison, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urquidi, V.
Right arrow Articles by Goodison, S.
Clinical Cancer Research Vol. 8, 61-74, January 2002
© 2002 American Association for Cancer Research


Cancer Biology, Immunology, Cytokines

Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis

Virginia Urquidi, Derek Sloan, Kanji Kawai, Dianne Agarwal, Anthony C. Woodman, David Tarin and Steve Goodison1

University of California, San Diego Cancer Center and Department of Pathology, University of California, San Diego, La Jolla, California 92093 [V. U., D. S., K. K., D. A., D. T., S. G.], and Cranfield BioMedical Centre, Institute of Bioscience and Technology, Cranfield, University, Bedfordshire, MK43 0AL, United Kingdom [A. C. W.]

Knowledge of the molecular mechanisms involved in metastatic spread is needed to facilitate advances in prognostic evaluation for individual patients and in the design of therapeutic interventions to inhibit the process. In an effort to establish a methodological framework for analysis of molecules and mechanisms involved in this complex multistep process, we have developed a well defined experimental system, in which the role of candidate genes can be screened and tested.

By serial dilution cloning of the MDA-MB-435 breast tumor cell line and screening by orthotopic implantation into the mammary fat pad of athymic mice, we have derived a pair of breast tumor cell lines (M-4A4 and NM-2C5) that originate from the same breast tumor but have diametrically opposite metastatic capabilities.

In 74% of inoculated athymic mice, clone M-4A4 metastasized consistently to the lungs, mimicking a major dissemination route of human breast cancer. Conversely, although equally tumorigenic, clone NM-2C5 did not metastasize to any distal site. We have confirmed that the cell lines originate from a single genetic source by spectral karyotyping and evaluated the expression of a number of proteins previously implicated in cellular transformation and metastasis. The ability of M-4A4 to metastasize was not associated with increased angiogenesis, as measured by immunohistochemical microvessel density analysis. However, RNA and protein analyses revealed that two secreted proteins were differentially expressed: osteopontin expression was increased ~30-fold in clone M-4A4 and thrombospondin-1 expression was increased ~15-fold in clone NM-2C5. These cell lines constitute a stable and accessible model for the identification of genes involved in the multistep process of breast tumor metastasis. Manipulation of candidate genes in these cells will permit evaluation of their functional significance in the geometric progression of breast cancer.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
R. Leth-Larsen, R. Lund, H. V. Hansen, A.-V. Laenkholm, D. Tarin, O. N. Jensen, and H. J. Ditzel
Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2009; 8(6): 1436 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
E. TERPOS, M. KIAGIA, E. M. KARAPANAGIOTOU, A. CHARPIDOU, K. D. DILANA, E. NASOTHIMIOU, K. J. HARRINGTON, A. POLYZOS, and K. N. SYRIGOS
The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications
Anticancer Res, May 1, 2009; 29(5): 1651 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. E. Talmadge
Clonal Selection of Metastasis within the Life History of a Tumor
Cancer Res., December 15, 2007; 67(24): 11471 - 11475.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
H. D. Shin, B. L. Park, H. S. Cheong, J.-H. Yoon, Y. J. Kim, and H.-S. Lee
SPP1 polymorphisms associated with HBV clearance and HCC occurrence
Int. J. Epidemiol., October 1, 2007; 36(5): 1001 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Suzuki, E. Mose, C. Galloy, and D. Tarin
Osteopontin Gene Expression Determines Spontaneous Metastatic Performance of Orthotopic Human Breast Cancer Xenografts
Am. J. Pathol., August 1, 2007; 171(2): 682 - 692.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Suzuki, E. S. Mose, V. Montel, and D. Tarin
Dormant Cancer Cells Retrieved from Metastasis-Free Organs Regain Tumorigenic and Metastatic Potency
Am. J. Pathol., August 1, 2006; 169(2): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Jang, T. Savarese, H. P. Low, S. Kim, H. Vogel, D. Lapointe, T. Duong, N. S. Litofsky, J. M. Weimann, A. H. Ross, et al.
Osteopontin Expression in Intratumoral Astrocytes Marks Tumor Progression in Gliomas Induced by Prenatal Exposure to N-Ethyl-N-Nitrosourea
Am. J. Pathol., May 1, 2006; 168(5): 1676 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Goodison, J. Yuan, D. Sloan, R. Kim, C. Li, N. C. Popescu, and V. Urquidi
The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer Cells
Cancer Res., July 15, 2005; 65(14): 6042 - 6053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Montel, T.-Y. Huang, E. Mose, K. Pestonjamasp, and D. Tarin
Expression Profiling of Primary Tumors and Matched Lymphatic and Lung Metastases in a Xenogeneic Breast Cancer Model
Am. J. Pathol., May 1, 2005; 166(5): 1565 - 1579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Montel, J. Kleeman, D. Agarwal, D. Spinella, K. Kawai, and D. Tarin
Altered Metastatic Behavior of Human Breast Cancer Cells after Experimental Manipulation of Matrix Metalloproteinase 8 Gene Expression
Cancer Res., March 1, 2004; 64(5): 1687 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Schneider, J. Yochim, J. Brabender, K. Uchida, K. D. Danenberg, R. Metzger, P. M. Schneider, D. Salonga, A. H. Holscher, and P. V. Danenberg
Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer
Clin. Cancer Res., March 1, 2004; 10(5): 1588 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. P. Manna and W. A. Frazier
CD47 Mediates Killing of Breast Tumor Cells via Gi-Dependent Inhibition of Protein Kinase A
Cancer Res., February 1, 2004; 64(3): 1026 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. D. Sloan, B. Nicholson, V. Urquidi, and S. Goodison
Detection of Differentially Expressed Genes in an Isogenic Breast Metastasis Model using RNA Arbitrarily Primed-Polymerase Chain Reaction Coupled with Array Hybridization (RAP-Array)
Am. J. Pathol., January 1, 2004; 164(1): 315 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. E. Korkola, S. DeVries, J. Fridlyand, E. S. Hwang, A. L. H. Estep, Y.-Y. Chen, K. L. Chew, S. H. Dairkee, R. M. Jensen, and F. M. Waldman
Differentiation of Lobular versus Ductal Breast Carcinomas by Expression Microarray Analysis
Cancer Res., November 1, 2003; 63(21): 7167 - 7175.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Zhang, B. He, and G. F. Weber
Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer
Mol. Cell. Biol., September 15, 2003; 23(18): 6507 - 6519.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck
{beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin
Mol. Cancer Res., September 1, 2003; 1(11): 810 - 819.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Goodison, K. Kawai, J. Hihara, P. Jiang, M. Yang, V. Urquidi, R. M. Hoffman, and D. Tarin
Prolonged Dormancy and Site-specific Growth Potential of Cancer Cells Spontaneously Disseminated from Nonmetastatic Breast Tumors as Revealed by Labeling with Green Fluorescent Protein
Clin. Cancer Res., September 1, 2003; 9(10): 3808 - 3814.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M. John, H. Leffler, B. Kahl-Knutsson, I. Svensson, and G. A. Jarvis
Truncated Galectin-3 Inhibits Tumor Growth and Metastasis in Orthotopic Nude Mouse Model of Human Breast Cancer
Clin. Cancer Res., June 1, 2003; 9(6): 2374 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Zijlstra, R. Mellor, G. Panzarella, R. T. Aimes, J. D. Hooper, N. D. Marchenko, and J. P. Quigley
A Quantitative Analysis of Rate-limiting Steps in the Metastatic Cascade Using Human-specific Real-Time Polymerase Chain Reaction
Cancer Res., December 1, 2002; 62(23): 7083 - 7092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.